Appointment
Prime Therapeutics bolsters its position as industry leader with 10 research studies at AMCP Nexus 2024
Prime Therapeutics
PR-10-24-NI-40Oct 11, 2024
Financing
AMD Drugs Market to Hit USD 17.37 Billion by 2029 with 10.7% CAGR | MarketsandMarkets™
MarketsandMarkets™
PR-09-24-NI-22Sep 27, 2024
Biopharma
Revolutionizing Autoimmune Disease Management with Soluble Bispecific Receptors
Gardiner Smith; Reiner Gentz, Ph.D.
Fab Biopharma
PR-09-24-NI-19Sep 27, 2024
Biopharma
AbZelectPRO™ enables biopharma customers to reach their research cell bank in 10 weeks with 8g/L
Abzena
PR-09-24-NI-18Sep 26, 2024
Biotech
Five Small Biotechs to Watch: October 2024
David Alvaro, Ph.D.
Pharma's Almanac
PR-09-24-NI-10Sep 23, 2024
Sustainability
Piramal Pharma’s GHG Commitment Validated and Approved by SBTi
Piramal Pharma Ltd.
PR-09-24-NI-04Sep 16, 2024
Female-Centric
Transforming Drug Development through a Female Perspective
Chia Chia Sun; William Freimuth, Ph.D., M.D.
Fab Biopharma
PAO-09-24-CL-03Sep 10, 2024
Developability
Mitigating Early Development Risks with Samsung Biologics DEVELOPICK™ Platform
Heonchang Lim
Samsung Biologics
PAO-09-24-CL-04Sep 04, 2024
Minitablets
Minitablets: Enhancing Safety and Palatability for Pediatric Medicines
Gus LaBella
Mikart
PAO-09-24-CL-01Aug 30, 2024
Drug Delivery
Nanocarriers to Overcome the Blood–Brain Barrier (BBB)
Serene Lee
Nice Insight
PAO-09-24-NI-01Aug 30, 2024
Changing Roles
How are Advancements in Technology Reshaping the Roles and Capabilities of CDMOs and CROs in the Drug Development Life Cycle?
Pharma's Almanac
PAO-08-24-RT-01Aug 07, 2024
Monoclonal Antibodies
Coriolis Pharma Launches U.S. Entity Alongside Innovative Drug Product Platform Service Offerings for Monoclonal Antibodies
Coriolis Pharma
PR-05-24-NI-02Jun 18, 2024
Protein Degradation
PROTACS: Upgrading Small Molecule Inhibitors
Cynthia A. Challener, Ph.D.
Pharma's Almanac
PAO-06-24-NI-02Jun 11, 2024
The PHASE Platform
How Synergistic Collaborations Between Outsourcing Partners Can Accelerate Clinical Success
Wheeler Bio
PAO-05-24-CL-01May 08, 2024
Nice Insight API Report
Small Molecule API Discovery and Development Trends
April Stanley, MS MBA
Nice Insight
PAO-03-24-NI-01Mar 21, 2024
Digital Pathology
Advancing Disease Research and Drug Development on an Enterprise Pathology Software Platform
Nathan Buchbinder
Proscia
PAO-01-24-CL-2Feb 29, 2024
Advanceability
Right from the Start: Designing Advanceable Formulations and Processes at Phase I
Serán Bioscience
PAO-02-24-CL-09Feb 26, 2024
CDMO - Small Biotech
Cis-Targeted Immunotherapies Need Large CDMO Expertise But Also Flexibility
Julie Trulson, Ph.D.
PAO-02-24-CL-07Feb 15, 2024
Tech Transfer
Transparent Communication Supports Tech Transfers Of Cis-targeted Immunotherapies
Julie Trulson, Ph.D.
PAO-02-24-CL-06Feb 15, 2024
Translation
The Translational Index Score: Improving the Entire Drug Development Cycle
Jo Varshney, Ph.D., D.V.M.
PAO-02-24-CL-10Feb 15, 2024